Ubs Group Ag Denali Therapeutics Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 141,403 shares of DNLI stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,403

Previous 136,223 3.8%

Holding current value

$3.04 Million

Previous $3.16 Million 30.22%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.96 - $31.05 $108,572 - $160,839	5,180 Added 3.8%	141,403 $4.12 Million
Q2 2024 Aug 13, 2024	SELL	$14.96 - $23.22 $3.11 Million - $4.82 Million	-207,656 Reduced 60.39%	136,223 $3.16 Million
Q1 2024 May 13, 2024	BUY	$15.83 - $23.35 $837,312 - $1.24 Million	52,894 Added 18.18%	343,879 $7.06 Million
Q4 2023 Feb 09, 2024	BUY	$16.2 - $23.18 $2.94 Million - $4.2 Million	181,289 Added 165.26%	290,985 $6.24 Million
Q3 2023 Nov 09, 2023	SELL	$20.63 - $30.17 $458,893 - $671,101	-22,244 Reduced 16.86%	109,696 $2.26 Million
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $107,244 - $151,253	4,589 Added 3.6%	131,940 $3.89 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $157,094 - $234,243	7,170 Added 5.97%	127,351 $2.93 Million
Q4 2022 Feb 08, 2023	BUY	$26.28 - $33.92 $2.04 Million - $2.64 Million	77,727 Added 183.09%	120,181 $3.34 Million
Q3 2022 Nov 10, 2022	BUY	$25.97 - $38.53 $936,971 - $1.39 Million	36,079 Added 565.95%	42,454 $1.3 Million
Q2 2022 Aug 10, 2022	SELL	$20.88 - $35.19 $683,548 - $1.15 Million	-32,737 Reduced 83.7%	6,375 $188,000
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $1.54 Million - $2.52 Million	-53,236 Reduced 57.65%	39,112 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $1.19 Million - $1.53 Million	27,868 Added 43.22%	92,348 $4.12 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $3.01 Million - $4.85 Million	62,043 Added 2545.88%	64,480 $3.25 Million
Q2 2021 Aug 13, 2021	SELL	$50.3 - $78.44 $1.4 Million - $2.18 Million	-27,792 Reduced 91.94%	2,437 $191,000
Q1 2021 May 12, 2021	BUY	$53.8 - $81.53 $1.31 Million - $1.99 Million	24,433 Added 421.55%	30,229 $1.73 Million
Q4 2020 Feb 11, 2021	SELL	$36.89 - $93.56 $17,006 - $43,131	-461 Reduced 7.37%	5,796 $485,000
Q3 2020 Nov 12, 2020	BUY	$23.13 - $38.84 $82,574 - $138,658	3,570 Added 132.86%	6,257 $224,000
Q2 2020 Jul 31, 2020	SELL	$16.01 - $28.82 $146,027 - $262,867	-9,121 Reduced 77.24%	2,687 $65,000
Q1 2020 May 01, 2020	BUY	$14.2 - $27.98 $134,900 - $265,810	9,500 Added 411.61%	11,808 $207,000
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $34,848 - $48,375	-2,420 Reduced 51.18%	2,308 $40,000
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $7,031 - $10,061	459 Added 10.75%	4,728 $72,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $4,976 - $7,569	269 Added 6.73%	4,269 $89,000
Q1 2019 May 14, 2019	SELL	$17.99 - $24.65 $1.34 Million - $1.84 Million	-74,485 Reduced 94.9%	4,000 $93,000
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $963,646 - $1.51 Million	69,427 Added 766.47%	78,485 $1.62 Million
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $174 - $304	14 Added 0.15%	9,058 $197,000
Q2 2018 Aug 14, 2018	SELL	$15.25 - $21.02 $28,746 - $39,622	-1,885 Reduced 17.25%	9,044 $138,000
Q1 2018 May 15, 2018	BUY	$15.36 - $24.8 $164,797 - $266,079	10,729 Added 5364.5%	10,929 $215,000
Q4 2017 Feb 14, 2018	BUY	$15.04 - $21.45 $3,008 - $4,290	200	200 $3,000

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account